OBJECTIVE To compare the efficacy of various concentrations and combinations of serum, EDTA, 3 tetracyclines, and N-acetylcysteine (NAC) for collagenase inhibition in an in vitro corneal degradation model.
SAMPLE Grossly normal corneas from recently euthanized dogs and horses and fresh serum from healthy dogs and horses.
PROCEDURES Serum was pooled by species for in vitro use. For each species, sections of cornea were dried, weighed, and incubated with clostridial collagenase (800 U/mL) in 5 mL of a 5mM calcium chloride-saline (0.9% NaCl) incubation solution and 500 μL of 1 of 19 treatments (homologous serum; 0.3%, 1.0%, or 2% EDTA; 0.1%, 0.5%, or 1.0% tetracycline, doxycycline, or minocycline; 0.5%, 1.0%, or 5.0% NAC; serum with 0.5% tetracycline; serum with 1.0% EDTA; or 1.0% EDTA with 0.5% tetracycline). Positive and negative control specimens were incubated with 5 mL of incubation solution with and without collagenase, respectively. Each control and treatment was replicated 4 times for each species. Following incubation, corneal specimens were dried and reweighed. The percentage corneal degradation was calculated and compared among treatments within each species.
RESULTS Treatments with tetracyclines at concentrations ≥ 0.5%, with EDTA at concentrations ≥ 0.3%, and with NAC at concentrations ≥ 0.5% were more effective at preventing corneal degradation than serum in both species. The efficacy of each combination treatment was equal to or less than that of its components.
CONCLUSIONS AND CLINICAL RELEVANCE Results suggested EDTA, tetracyclines, and NAC may be beneficial for topical treatment of keratomalacia, but in vivo studies are required.
Objective—To determine whether differences exist in the calculated intraocular lens (IOL) strengths of a population of adult horses and to assess the association between calculated IOL strength and horse height, body weight, and age, and between calculated IOL strength and corneal diameter.
Animals—28 clinically normal adult horses (56 eyes).
Procedures—Axial globe lengths and anterior chamber depths were measured ultrasonographically. Corneal curvatures were determined with a modified photokeratometer and brightness-mode ultrasonographic images. Data were used in the Binkhorst equation to calculate the predicted IOL strength for each eye. The calculated IOL strengths were compared with a repeated-measures ANOVA. Corneal curvature values (photokeratometer vs brightness-mode ultrasonographic images) were compared with a paired t test. Coefficients of determination were used to measure associations.
Results—Calculated IOL strengths (range, 15.4 to 30.1 diopters) differed significantly among horses. There was a significant difference in the corneal curvatures as determined via the 2 methods. Weak associations were found between calculated IOL strength and horse height and between calculated IOL strength and vertical corneal diameter.
Conclusions and Clinical Relevance—Calculated IOL strength differed significantly among horses. Because only weak associations were detected between calculated IOL strength and horse height and vertical corneal diameter, these factors would not serve as reliable indicators for selection of the IOL strength for a specific horse.
To assess the impact of prophylactic omeprazole and famotidine on the incidence and severity of gastrointestinal (GI) adverse events (AEs) in dogs with cancer treated with single agent piroxicam.
39 dogs with a cytologic or histologic diagnosis of cancer with no history of GI disease and received piroxicam.
A prospective, randomized, placebo-controlled, double-blinded clinical trial was performed. All dogs received piroxicam (0.3 mg/kg [0.14 mg/lb], PO, q 24 h) and either omeprazole (1 mg/kg [0.45 mg/lb], PO, q 12 h), famoti-dine (1 mg/kg, PO, q 12 h), or placebo (lactose; PO, q 12 h). Monthly assessments of GI AEs were performed and scored by using the Veterinary Comparative Oncology Group's Common Terminology Criteria for Adverse Events (version 1.1).
Compared with dogs in the placebo group, more dogs in the omeprazole group (84.6% vs 36.4%) and famotidine group (80.0% vs 36.4%) experienced GI AEs by day 56. The severity of GI AEs was higher in the omeprazole group, compared with the placebo group.
CONCLUSIONS AND CLINICAL RELEVANCE
Omeprazole was not helpful in reducing the frequency or severity of GI AEs and was associated with more frequent and severer GI AEs in dogs with cancer treated with single agent piroxicam. Proton-pump inhibitors and H2-receptor antagonists should not be prescribed as prophylaxis with NSAIDs for dogs with cancer. (J Am Vet Med Assoc 2021;259:385-391)
Objective—To evaluate the management of equids undergoing cryptorchidectomy at a referral hospital.
Design—Retrospective case series.
Animals—604 client-owned equids.
Procedures—Medical records of all equids undergoing surgical treatment of cryptorchidism from 1977 to 2010 were retrospectively reviewed. Analyses of breed, location of retained testes, accuracy of palpation per rectum for determining the location of retained testes, surgical technique, and postoperative complications were performed.
Results—The most frequently affected breed was the Quarter Horse (282/604 [47%]), which was significantly overrepresented. Of the 604 equids, 90 (15%) had undergone previous surgical attempts at castration. Preoperative palpation per rectum was performed in 395/604 (65.4%) patients, and was accurate in predicting the location of the retained testes in 354/395 (89.6%). Surgeons were significantly more likely to be incorrect in determining the location of the retained testis by means of palpation per rectum in patients that had undergone a prior attempt at castration. For equids with abdominal cryptorchidism (360/604 [59.6%]), the most common surgical technique was noninvasive cryptorchidectomy (298/360 [82.8%]). In unilateral cryptorchids (521/604 [86.3%]), the 2 most common sites were left abdominal (184/521 [35.3%]) and right inguinal (148/521 [28.4%]). For bilateral retention (80/604 [13.2%]), abdominal cryptorchidism was most common (48/80 [60%]). Fever was present in 138/324 (43%) equids on the first day after surgery. Postoperative fever was not significantly associated with any variables evaluated. Including postoperative (≤ 24 hours) fever, 150 of 604 (25%) patients developed postoperative complications. Excluding postoperative fever, 18 of 604 (3%) patients developed major postoperative complications; complications in 10 of 604 patients were deemed surgically related, and 3 of 604 patients died.
Conclusions and Clinical Relevance—Results indicated that cryptorchidectomy in equids performed with a variety of surgical approaches was associated with minimal postoperative complications. A history of previous attempts at castration decreased the ability to accurately predict the location of the retained testis.
OBJECTIVE To evaluate reproductive performance and productive longevity of dairy cows treated for left displaced abomasum (LDA) with 1 of 2 surgical techniques (omentopexy vs pyloro-omentopexy).
DESIGN Retrospective case series.
ANIMALS 87 Holstein cows that underwent omentopexy or pyloro-omentopexy for LDA during a 5-year period.
PROCEDURES For each cow with LDA, the most recent date of calving, age at time of surgery, and surgical procedure were recorded. Dairy records of cows treated for LDA in the 5-year period were reviewed to determine their reproductive performance. Records available for up to 4 years after the last surgery (ie, when all treated cows had left the herd) were reviewed to determine cull dates and reasons for treated and untreated cows in the herd.
RESULTS Of the 87 cows with LDA, 58 underwent pyloro-omentopexy and 29 underwent omentopexy. Cows in the 2 treatment groups did not significantly differ in age. Fifty-six cows completed > 1 subsequent lactation cycle after surgery. The median time that cows with LDA remained in the herd was 566 days (range, 24 to 1,838 days); the times for the 2 treatment groups did not significantly differ. For treated and untreated cows, cull rates for reproductive failure or other problems were similar. Four (14%) omentopexy–treated cows and no pyloro-omentopexy–treated cows had a reoccurrence of LDA.
CONCLUSIONS AND CLINICAL RELEVANCE Results indicated that cows with LDA that underwent omentopexy or pyloro-omentopexy had similar cull rates and reasons as unaffected herd mates over their productive time in the herd. Between the 2 treatment groups, only the LDA reoccurrence rate differed.
Objective—To estimate prevalence of intestinal nematode parasitism among pet dogs in the United States and characterize risk factors for infection.
Design—Retrospective period prevalence survey.
Animals—1,213,061 dogs examined at 547 private veterinary hospitals in 44 states from January 1, 2003, through December 31, 2006.
Procedures—Data were obtained from electronic medical records of all dogs that had at least 1 fecal flotation test. Risk factors for intestinal nematode parasitism were identified by means of multivariable logistic regression analysis.
Results—2,785,248 fecal flotation tests were performed during the study period. When results for only the first test in each dog were considered, prevalences of Toxocara, Ancylostoma, and Trichuris parasitism were 5.04%, 4.50%, and 0.81%, respectively. Dogs < 0.5 years old had higher odds of Toxocara and Ancylostoma parasitism, compared with dogs > 5.0 years old; sexually intact male and female dogs had higher odds of parasitism, compared with spayed female dogs; toy dogs had lower odds of parasitism, compared with dogs in other breed groups; and dogs living in the mountain region had lower odds of parasitism, compared with dogs living in other regions.
Conclusions and Clinical Relevance—Results suggested that age, body weight, sex, breed, and geographic region were risk factors for intestinal nematode parasitism among pet dogs in the United States.
Objective—To evaluate the effect of multiple hydrogen peroxide gas plasma (HPGP) sterilizations on the rate of closure of ameroid constrictors.
Sample—Thirty-six 5.0-mm ameroid constrictors.
Procedures—Ameroid constrictors were randomly allocated to 6 groups. Each group underwent 1, 2, 3, 4, 5, or 6 HPGP sterilizations. Ameroid constrictors were then incubated for 35 days in canine plasma and digitally imaged at predetermined times during incubation. One individual, who was unaware of the group to which each ameroid constrictor was assigned, measured the lumen area of the constrictor on each digital image. Mean lumen area was compared among groups.
Results—No ameroid constrictors were completely closed after 35 days of incubation in canine plasma. Mean lumen area after incubation did not differ among constrictors that underwent 1, 2, and 3 sterilizations. Constrictors that underwent 4 sterilizations were closed significantly more than were those that underwent 1, 2, or 3 sterilizations. Mean lumen area after incubation did not differ significantly between constrictors that underwent 5 and 6 sterilizations, although the final lumen areas for those constrictors were significantly smaller than those for constrictors that underwent 1, 2, 3, and 4 sterilizations.
Conclusions and Clinical Relevance—Ameroid constrictors that underwent 5 and 6 HPGP sterilizations had a 9% to 12% decrease in lumen area, compared with that of constrictors that underwent ≤ 4 plasma sterilizations, and the use of such constrictors could increase the risk of portal hypertension and secondary acquired shunting or decrease the risk of persistent shunting.
OBJECTIVE To evaluate the effect of a bovine albumin–derivatized glutaraldehyde (BA-DG) biopolymer sealant on leakage pressures of intestinal anastomoses in jejunal tissue collected from fresh canine cadavers and to evaluate changes in circumference and cross-sectional area of the anastomotic site resulting from sealant application.
SAMPLE 24 jejunal anastomoses from 4 fresh canine cadavers.
PROCEDURES Jejunal tissue specimens were collected, and adjacent segment anastomoses were created within 12 hours after euthanasia of each dog. The tissue constructs were randomly assigned to 1 of 2 groups in which sealant was or was not applied. The outer circumference of all anastomoses in the sealant group was measured before and after application of the sealant; the cross-sectional area at the anastomotic site was then calculated at each time point. Tissue constructs were pressure tested, and leakage pressure and site were recorded. All testing was completed within 24 hours after tissue collection.
RESULTS Compared with preapplication findings, there were no significant changes in outer circumference or cross-sectional area at the anastomotic site after sealant application. Leakage pressures in the sealant group were significantly higher than those in the no-sealant group.
CONCLUSIONS AND CLINICAL RELEVANCE The use of surgical sealant on fresh canine cadaver jejunal anastomoses resulted in significantly higher leakage pressure at the anastomotic site; no immediate tissue deformation of the outer circumference or cross-sectional area occurred after sealant application. Future in vivo investigations are warranted to evaluate the effects of this sealant and potential benefits for clinical patients undergoing enterectomy.